SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Investing in Exponential Growth
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Paul H. Christiansen8/23/2016 4:30:55 AM
   of 1084
 
Little Known Surgical Robot Stock Mazor Robotics

Last month we wrote about 10 companies building surgical robots. There were at least 3 key takeaways from that article as follows:

· There is a lot of money to be made in this space. Investors in the biggest publicly traded surgical robot company, Intuitive Surgical (NASDAQ:ISRG), made a return of +3,687% over the past 16 years.

· Dismiss any notions you might have of actually being operated upon by an autonomous robot. Surgical robots are always assisted by humans at the present time.

· The majority of exciting surgical robot companies are private and there aren’t many pure-play opportunities for retail investors in this space

In light of this information, we were pleasantly surprised to discover a promising surgical robot stock recently, Mazor Robotics (NASDAQ:MZOR), which may be worth a closer look for retail investors.

Founded in 2000, Israeli company Mazor Robotics has a flagship spinal surgery system called the Renaissance which has been used to perform over 16,000 procedures worldwide, many of which would not have been possible without their technology. In 2014 they introduced the Renaissance for brain surgery and continue developing the platform for additional spine and brain surgery procedures. In May of this year MZOR stock nearly doubled when Medtronic (NYSE:MDT) entered into an agreement with them, the highlights of which are as follows:

· There is a U.S. based co-promotion phase which involves MDT buying 15 surgical robot systems in 2016

· If all milestones are met by end of 2017, Medtronic assumes exclusive global sales rights for MZORs spine products

· An $11.9 million investment is being made by MDT along with 2 follow on investments capped at $20 million apiece

http://www.nanalyze.com/2016/08/surgical-robot-stock-mazor-robotics/

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News